Sector Breakdown: Where the Cheap Growth Is Hiding (and Where It Isn't)
Synthos Research — Sector Breakdown · The cross-sector screen Every name below is ranked by one question: how cheap is it relative to its own growth and
S&P 500$741 ▲ +1.6%Nasdaq 100$724 ▲ +2.5%Russell 2000$299 ▼ -0.3%Dow 30$522 ▲ +0.8%Gold (GLD)$369 ▼ -1.4%Bitcoin$59,496 ▼ -1.1%UST 2y 4.07% · 10y 4.38% · 30y 4.87%
AI-native investment research
Synthesizing signals
into one thesis.
Six analysts each touch a different part of the elephant. Synthos holds all of them at once — six sectors, the global macro regime, and thousands of primary sources, synthesized into one clear thesis.
The weekly regime read + one signal — free, every week. No spam. Unsubscribe anytime.
The edge
Three things you can't get from a generic newsletter.
Regime
Macro & turbulence signal
Global fiscal/monetary space, sector rotation across all 11 SPDRs, and a Mahalanobis turbulence index that flags risk-off before the surface cracks.
Systematic
Screens, valuations & clinical POS
Cross-sector cheap-for-growth screens, DCF valuations, and a base-rate clinical probability engine for biotech catalysts — the binary risk most investors ignore.
Novel
The Forecaster Scorecard
We structure thousands of dated predictions from the people you follow — and track who is actually right. Finally, an answer to "whose calls should I trust?"
Latest research
Market Status: No Landing, Sticky Inflation, and a Tape That Won't Quit
Synthos Research — Market Status · The weekly regime read The one-line read: risk assets are climbing a wall of sticky inflation, and our turbulence model says
Circle (CRCL): A Real Theme, a Questionable Vehicle
Synthos Research — Company Deep Dive · Price at analysis: $75.96 · Financials / Stablecoin infrastructure · IPO'd June 2025 The bottom line Synthos rating Exponential Potential 48
Eli Lilly (LLY): A Magnificent Business, Priced for It
Synthos Research — Company Deep Dive · Price at analysis: $1,206.51 · Market cap: $1,136B · Healthcare / Drug Manufacturers The bottom line Synthos rating Exponential Potential 87
Coming soon
This is Synthos Research, a brand new site by Ari Sagherian that's just getting started. Things will be up and running here shortly, but
Pricing
Start free. Upgrade when the edge pays for itself.
Free
$0
- The weekly macro regime read
- One cross-sector signal each week
- The big-picture view
All-Access
$19/mo
or $199/yr (save ~13%) · start with a 7-day free trial
- Every sector — screens, leaderboards & DCF valuations
- Catalyst calendar + clinical probability (POS) scores
- Model portfolios & the turbulence dial
- The Forecaster Scorecard
- The full weekly market update + archive
Disclaimer. Synthos Research is an independent research publication for
educational and informational purposes only. Nothing here is investment advice, a
solicitation, or a recommendation to buy or sell any security, and it is not personalized to
your situation. Markets are risky; do your own due diligence and consult a licensed
professional. The author may hold positions in securities discussed.